Ryan Lake - Dec 15, 2021 Form 4 Insider Report for Recro Pharma, Inc. (SCTL)

Role
Chief Financial Officer
Signature
By: Ryan D. Lake
Stock symbol
SCTL
Transactions as of
Dec 15, 2021
Transactions value $
-$9,161
Form type
4
Date filed
12/17/2021, 06:36 PM
Previous filing
Nov 16, 2021
Next filing
Jan 4, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction SCTL Common Stock Tax liability -$9.16K -5.69K -1.52% $1.61 369K Dec 15, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Shares withheld by the Company to satisfy applicable withholding taxes upon vesting of restricted stock units.